Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.

S Al-SamsamJ BartošV ŠámalJan DvořákH KolářováI Richter

Published in: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti (2024)

Our analysis demonstrated efficacy and good tolerance in patients with mCRPC treated with enzalutamide and abiraterone after previous docetaxel therapy.

Keyphrases

prostate cancer
locally advanced
newly diagnosed
stem cells
rectal cancer
data analysis